XS7-19444-34193
4 vaccinations
3 coded responses
42 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 641 / MO
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
4RU-10096-48567
Child or adolescent in my care · Male · 2022-06-25
QLZ-29014-64850
Child or adolescent in my care · Female · 2022-06-25
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
-
2021-10-08
Survey response — 6 months, dose 2MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Paranasal sinus discomfort — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus pressure, nasal congestion, sore throat, coughMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-13
-
2021-11-21
Dose 3 — Moderna
- 2021-11-21
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2021-12-19
- 2021-12-26
- 2022-01-02
-
2022-02-20
Survey response — 3 months, dose 3MedDRA: Nausea, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pregnancy, nauseaMedDRA releases: 2024-11 · check-in free text available
- 2022-05-23
-
2022-09-08
Dose 4 — Pfizer-BioNTech
-
2022-11-21
Survey response — 12 months, dose 3MedDRA: Labyrinthitis, Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Unknown viral infection, labyrinthitisMedDRA releases: 2024-11 · check-in free text available
-
2022-11-21
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-11-22
- 2022-11-22
- 2022-12-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-11-21 | Moderna | No |
| 4 | 2022-09-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-08 | Unsuccessful | |
| 2022-11-21 | Unsuccessful |
Free text
Release 10 — 6 months, dose 2
Symptoms: Sinus pressure, nasal congestion, sore throat, cough
Release 11 — 3 months, dose 3
Symptoms: Pregnancy, nausea
Release 12 — 12 months, dose 3
Symptoms: Unknown viral infection, labyrinthitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Labyrinthitis | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release